ASVRX | NDVUX | ASVRX / NDVUX | |
Total Expense Ratio | 1.58 | 0.96 | 165% |
Annual Report Gross Expense Ratio | 1.58 | 0.97 | 163% |
Fund Existence | 16 years | 14 years | - |
Gain YTD | 0.506 | 0.955 | 53% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 4.65B | 2.87B | 162% |
Annual Yield % from dividends | 0.39 | 1.48 | 26% |
Returns for 1 year | 0.01 | 0.70 | 1% |
Returns for 3 years | 10.72 | 7.19 | 149% |
Returns for 5 years | 58.56 | 44.24 | 132% |
Returns for 10 years | 23.42 | 58.91 | 40% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
ITRAX | 24.36 | 0.03 | +0.12% |
VY® T. Rowe Price Capital Apprec A | |||
DFSGX | 25.45 | 0.03 | +0.12% |
DF Dent Small Cap Growth Institutional | |||
NQVCX | 55.55 | -0.04 | -0.07% |
Nuveen Multi Cap Value C | |||
MVISX | 51.09 | -0.14 | -0.27% |
Patient Opportunity IS | |||
FTMSX | 26.87 | -0.12 | -0.44% |
FullerThaler Behvrl Mcr-Cp Eq Instl |